219 related articles for article (PubMed ID: 17575540)
41. Preoperative serum carcinoembryonic antigen and carbohydrate antigen 19-9 levels for the evaluation of curability and resectability in patients with pancreatic adenocarcinoma.
Fujioka S; Misawa T; Okamoto T; Gocho T; Futagawa Y; Ishida Y; Yanaga K
J Hepatobiliary Pancreat Surg; 2007; 14(6):539-44. PubMed ID: 18040617
[TBL] [Abstract][Full Text] [Related]
42. Usefulness of plasma vascular endothelial growth factor in the diagnosis of pancreatic carcinoma: differential diagnosis, tumor progression, and patient survival.
Kobayashi A; Yamaguchi T; Ishihara T; Ohshima T; Baba T; Shirai Y; Tadenuma H; Nakamura K; Saisho H
Pancreas; 2005 Jul; 31(1):74-8. PubMed ID: 15968251
[TBL] [Abstract][Full Text] [Related]
43. Distinguishing pancreatic cancer from chronic pancreatitis and healthy individuals by (1)H nuclear magnetic resonance-based metabonomic profiles.
Zhang L; Jin H; Guo X; Yang Z; Zhao L; Tang S; Mo P; Wu K; Nie Y; Pan Y; Fan D
Clin Biochem; 2012 Sep; 45(13-14):1064-9. PubMed ID: 22613268
[TBL] [Abstract][Full Text] [Related]
44. Comparative evaluation of p53 mutation in pancreatic adenocarcinoma and chronic pancreatitis.
Talar-Wojnarowska R; Gasiorowska A; Smolarz B; Romanowicz-Makowskal H; Strzelczyk J; Janiak A; Malecka-Panas E
Hepatogastroenterology; 2006; 53(70):608-12. PubMed ID: 16995472
[TBL] [Abstract][Full Text] [Related]
45. Potentials of plasma NGAL and MIC-1 as biomarker(s) in the diagnosis of lethal pancreatic cancer.
Kaur S; Chakraborty S; Baine MJ; Mallya K; Smith LM; Sasson A; Brand R; Guha S; Jain M; Wittel U; Singh SK; Batra SK
PLoS One; 2013; 8(2):e55171. PubMed ID: 23383312
[TBL] [Abstract][Full Text] [Related]
46. CA19-9 serum levels in obstructive jaundice: clinical value in benign and malignant conditions.
Marrelli D; Caruso S; Pedrazzani C; Neri A; Fernandes E; Marini M; Pinto E; Roviello F
Am J Surg; 2009 Sep; 198(3):333-9. PubMed ID: 19375064
[TBL] [Abstract][Full Text] [Related]
47. Amino acid malnutrition in patients with chronic pancreatitis and pancreatic carcinoma.
Schrader H; Menge BA; Belyaev O; Uhl W; Schmidt WE; Meier JJ
Pancreas; 2009 May; 38(4):416-21. PubMed ID: 19169171
[TBL] [Abstract][Full Text] [Related]
48. Serum DJ-1 as a diagnostic marker and prognostic factor for pancreatic cancer.
He XY; Liu BY; Yao WY; Zhao XJ; Zheng Z; Li JF; Yu BQ; Yuan YZ
J Dig Dis; 2011 Apr; 12(2):131-7. PubMed ID: 21401899
[TBL] [Abstract][Full Text] [Related]
49. Establishment and Verification of a Scoring Model for the Differential Diagnosis of Pancreatic Cancer and Chronic Pancreatitis.
Zhang H; Han W; Jin M; Lai Y; Wang X; Wang J; Yao Y; Wu D; Qian J; Yang H
Pancreas; 2018 Apr; 47(4):459-465. PubMed ID: 29517635
[TBL] [Abstract][Full Text] [Related]
50. Tissue polypeptide specific antigen (TPS), a marker for differentiation between pancreatic carcinoma and chronic pancreatitis. A comparative study with CA 19-9.
Slesak B; Harlozinska-Szmyrka A; Knast W; Sedlaczek P; van Dalen A; Einarsson R
Cancer; 2000 Jul; 89(1):83-8. PubMed ID: 10897004
[TBL] [Abstract][Full Text] [Related]
51. EUS/EUS-FNA for suspected pancreatic cancer: influence of chronic pancreatitis and clinical presentation with or without obstructive jaundice on performance characteristics.
Krishna NB; Mehra M; Reddy AV; Agarwal B
Gastrointest Endosc; 2009 Jul; 70(1):70-9. PubMed ID: 19249774
[TBL] [Abstract][Full Text] [Related]
52. Verification of the effectiveness of fucosylated haptoglobin as a pancreatic cancer marker in clinical diagnosis.
Kuwatani M; Kawakami H; Kubota Y; Kawakubo K; Ito YM; Togo S; Ikeda T; Kusama K; Kobayashi Y; Murata T; Sakamoto N
Pancreatology; 2019 Jun; 19(4):569-577. PubMed ID: 31031206
[TBL] [Abstract][Full Text] [Related]
53. Findings on endoscopic retrograde cholangiopancreatography and pancreatic function test in suspected chronic pancreatitis and negative cross-sectional imaging.
Parsi MA; Conwell DL; Zuccaro G; Stevens T; Lopez R; Dumot JA; Vargo JJ
Clin Gastroenterol Hepatol; 2008 Dec; 6(12):1432-6. PubMed ID: 19081531
[TBL] [Abstract][Full Text] [Related]
54. Diagnostic and prognostic value of plasma tumor M2 pyruvate kinase in periampullary cancer: evidence for a novel biological marker of adverse prognosis.
Goonetilleke KS; Mason JM; Siriwardana P; King NK; France MW; Siriwardena AK
Pancreas; 2007 Apr; 34(3):318-24. PubMed ID: 17414054
[TBL] [Abstract][Full Text] [Related]
55. CA 19-9 as a predictor for response and survival in advanced pancreatic cancer patients treated with chemoradiotherapy.
Koom WS; Seong J; Kim YB; Pyun HO; Song SY
Int J Radiat Oncol Biol Phys; 2009 Mar; 73(4):1148-54. PubMed ID: 18760544
[TBL] [Abstract][Full Text] [Related]
56. Usefulness of MALDI-TOF/MS identification of low-MW fragments in sera for the differential diagnosis of pancreatic cancer.
Padoan A; Seraglia R; Basso D; Fogar P; Sperti C; Moz S; Greco E; Marchet A; de Manzoni G; Zambon CF; Navaglia F; Cristadoro L; Di Chiara A; Nitti D; Pedrazzoli S; Pavanello G; Plebani M
Pancreas; 2013 May; 42(4):622-32. PubMed ID: 23271396
[TBL] [Abstract][Full Text] [Related]
57. Osteopontin as a discriminating marker for pancreatic cancer and chronic pancreatitis.
Rychlíková J; Vecka M; Jáchymová M; Macášek J; Hrabák P; Zeman M; Vávrová L; Řoupal J; Krechler T; Ák A
Cancer Biomark; 2016 Jun; 17(1):55-65. PubMed ID: 27314293
[TBL] [Abstract][Full Text] [Related]
58. [Immunohistochemical study of mucins in chronic pancreatitis and ductal adenocarcinoma of the pancreas].
Paklina OV; Setdikova GR
Arkh Patol; 2008; 70(4):13-7. PubMed ID: 18807519
[TBL] [Abstract][Full Text] [Related]
59. Decreased serum adiponectin levels in patients with metastatic renal cell carcinoma.
Horiguchi A; Ito K; Sumitomo M; Kimura F; Asano T; Hayakawa M
Jpn J Clin Oncol; 2008 Feb; 38(2):106-11. PubMed ID: 18245516
[TBL] [Abstract][Full Text] [Related]
60. CA 19-9 to differentiate benign and malignant masses in chronic pancreatitis: is there any benefit?
Bedi MM; Gandhi MD; Jacob G; Lekha V; Venugopal A; Ramesh H
Indian J Gastroenterol; 2009; 28(1):24-7. PubMed ID: 19529898
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
